Not that anyone reads these posts - but might one day - MSB just saw an intra-day mkt cap jump of some $60 million simply on an FDA designation of one of its applications as a Rare Pediatric Disease (RPD) Designation. Such 'vouchers' are tradeable and have fetched somewhere between $20-$350 million in the past:
https://www.prnewswire.com/news-releases/united-therapeutics-corporation-agrees-to-sell-priority-review-voucher-to-abbvie-for-350-million-300130415.html#:~:text=Upon%20closing%20of%20the%20transaction,treatment%20of%20rare%20pediatric%20diseases.
IP is very difficult to value, but when companies literally trade designations with each other it gives more tangible insight to the potential valuation involved.
- Forums
- ASX - By Stock
- Ann: Chairman's Address and CEO update
Not that anyone reads these posts - but might one day - MSB just...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CMB (ASX) to my watchlist
|
|||||
Last
35.5¢ |
Change
0.005(1.43%) |
Mkt cap ! $4.235M |
Open | High | Low | Value | Volume |
35.0¢ | 35.5¢ | 35.0¢ | $141 | 403 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1327 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.5¢ | 259 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1327 | 0.350 |
1 | 1700 | 0.300 |
1 | 2000 | 0.290 |
1 | 2500 | 0.200 |
1 | 3000 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.355 | 259 | 1 |
0.415 | 981 | 1 |
0.420 | 1910 | 1 |
0.450 | 6000 | 1 |
0.500 | 2135 | 2 |
Last trade - 11.49am 19/08/2024 (20 minute delay) ? |
Featured News
CMB (ASX) Chart |